Menu Search
Equities

Verona Pharma PLC

VRNA:NMQ

Verona Pharma PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)29.40
  • Today's Change0.17 / 0.58%
  • Shares traded566.51k
  • 1 Year change+70.58%
  • Beta0.4344
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Verona Pharma PLC increased its cash reserves by 19.29%, or 43.95m. Cash Flow from Financing totalled 92.87m or -- of revenues. In addition the company used 50.22m for operations while cash from investing was breakeven.
Cash flow per share-1.55
Price/Cash flow per share--
Book value per share2.08
Tangible book value per share2.07
More ▼

Balance sheet in USDView more

Verona Pharma PLC appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 271.77m.
Current ratio8.61
Quick ratio--
Total debt/total equity0.7113
Total debt/total capital0.4156
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.